Figure 3
From: Overcoming radioresistance of breast cancer cells with MAP4K4 inhibitors
MAP4K4 inhibitor suppressed tumor growth in mice bearing SR tumor. (A) The experimental scheme used for testing the anti-tumor effects of PF06260933 (PF) in vivo. (B) No loss of body weight occurred in mice treated with PF06260933. (C) Tumor growth in SR tumor-bearing BALB/c nude mice treated with PF06260933 (n = 4). (D) Final tumor volume on day of sacrifice. * indicates P value of < 0.05 versus control group.
